NCT04367545View on ClinicalTrials.gov

Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

May 17, 2020

Study Completion Date

May 17, 2020

Conditions
COVIDRT-ddPCR Multiplex
Interventions
DIAGNOSTIC_TEST

Saliva collection

Saliva collection will be done in addition to standard diagnosis collection (nasopharyngeal collection using swab)

Trial Locations (1)

Unknown

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT04367545 - Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter